Introduction
In an age where precision medicine is becoming paramount, EpiSign Inc., a Canadian biotech start-up, is making waves with its latest offering: METRIC. This innovative cloud-based software platform is designed to revolutionize the way epigenomic diagnostics are accessed and interpreted across the globe.
What is METRIC?
Launched on October 15, 2025, METRIC stands for Methylation-based Episignature Testing and Reference-based Interpretation Classification. The platform is rooted in over a decade of scientific research and has been crafted to enable healthcare professionals to translate complex epigenomic data into insightful clinical information.
Features and Benefits
One of the key strengths of EpiSign METRIC is its ability to streamline clinical workflows. It integrates effortlessly with existing hardware and software systems, providing a cohesive user experience. Through the use of advanced AI algorithms, METRIC not only enhances efficiency but also accelerates turnaround times, delivering crucial insights to clinicians faster than ever before.
President and CEO of EpiSign, Dan Sinai, expressed the significance of this launch, stating that METRIC will bring validated episignature interpretation directly to the point of care. This development is a game-changer for patients and healthcare systems alike, offering quicker and more reliable diagnostic solutions.
Robust Technology
EpiSign METRIC is built with the latest technology, allowing for automated classification, rigorous quality control, and centralized reporting. This ensures that interpretable data is consistently produced across different medical sites. Dr. Bekim Sadikovic, the Chief Scientific Officer at EpiSign, claims that METRIC is designed to operationalize significant epigenomic discoveries, promising a reproducible interpretation of results. It utilizes reference-based models that match patient methylation data against validated episignatures, simplifying the reporting process for clinicians.
The platform currently supports screening for over 200 episignature disorders, with ambitions to expand this number to 1,000 syndromes within the next five years. This adaptability reflects EpiSign's commitment to continuous advancement, making it an attractive option for healthcare providers focused on comprehensive patient care.
Collaboration and Validation
EpiSign has established collaborations with over 125 institutions in 25 countries, ensuring that METRIC is informed by a wide variety of clinical data. Such extensive collaboration not only boosts the platform's credibility but also emphasizes EpiSign's goal of making epigenomic diagnostics accessible worldwide.
Clinical Laboratory Geneticist, Mariëlle Alders, noted that METRIC represents a pivotal movement toward integrating DNA methylation episignatures into regular diagnostic practices. Future updates promise to extend capabilities, potentially incorporating advanced sequencing technologies, which will further enrich the scope of disease and exposure-related information available through the platform.
Scalability and Data Security
Moreover, METRIC is designed to support high-throughput workflows and multi-lab collaborations, all while adhering to stringent data privacy and security protocols. This is particularly advantageous for laboratories and hospital systems, as it allows for enhanced performance, reduced turnaround times, and integration into current laboratory information systems (LIS) and clinical review processes.
For both clinicians and patients, the benefits are clear: quicker answers and more detailed insights into diagnostic data.
Conclusion
In conclusion, EpiSign METRIC marks a significant step forward in the field of precision epigenomics. It empowers diagnostic labs to analyze and interpret data independently and in real-time, transforming the approach to episignature analysis. With automation, scalability, and user transparency at its core, EpiSign METRIC is poised to change the landscape of epigenomic diagnostics for years to come.
To learn more about EpiSign METRIC and its groundbreaking features, visit
EpiSign's official site.